BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 23565522)

  • 21. Glucocorticosteroid-induced spinal osteoporosis: scientific update on pathophysiology and treatment.
    Popp AW; Isenegger J; Buergi EM; Buergi U; Lippuner K
    Eur Spine J; 2006 Jul; 15(7):1035-49. PubMed ID: 16474946
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Anabolic steroids in corticosteroid-induced osteoporosis.
    Adami S; Rossini M
    Wien Med Wochenschr; 1993; 143(14-15):395-7. PubMed ID: 8256456
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Medication-induced osteoporosis.
    Weng MY; Lane NE
    Curr Osteoporos Rep; 2007 Dec; 5(4):139-45. PubMed ID: 18430387
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical question: What is the best approach to managing glucocorticoid-induced osteoporosis?
    Compston J
    Clin Endocrinol (Oxf); 2011 May; 74(5):547-50. PubMed ID: 21470278
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Heat shock protein 60 protects skeletal tissue against glucocorticoid-induced bone mass loss by regulating osteoblast survival.
    Wang FS; Wu RW; Ko JY; Tai MH; Ke HC; Yeh DW; Wu SL; Chen MW
    Bone; 2011 Nov; 49(5):1080-9. PubMed ID: 21854881
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Glucocorticoid induced risk of fractures.
    Maruotti N; Corrado A; Cantatore FP
    Panminerva Med; 2010 Dec; 52(4):339-43. PubMed ID: 21183894
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Drug-induced bone loss: a major safety concern in Europe.
    Nguyen KD; Bagheri B; Bagheri H
    Expert Opin Drug Saf; 2018 Oct; 17(10):1005-1014. PubMed ID: 30222369
    [TBL] [Abstract][Full Text] [Related]  

  • 28. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Pathogenesis, prevention and therapy of steroid osteoporosis].
    Dambacher MA; Olah AJ; Maurer H; Gampp R; Rüegsegger P
    Z Orthop Ihre Grenzgeb; 1990; 128(3):234-9. PubMed ID: 2144069
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prevention and treatment of glucocorticoid-induced osteoporosis: a comparison of calcitriol, vitamin D plus calcium, and alendronate plus calcium.
    Sambrook PN; Kotowicz M; Nash P; Styles CB; Naganathan V; Henderson-Briffa KN; Eisman JA; Nicholson GC
    J Bone Miner Res; 2003 May; 18(5):919-24. PubMed ID: 12733733
    [TBL] [Abstract][Full Text] [Related]  

  • 31. What is new in the treatment of steroid-induced osteoporosis?
    Liu RH; Werth VP
    Semin Cutan Med Surg; 2006 Jun; 25(2):72-8. PubMed ID: 16908396
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Glucocorticoid-induced osteoporosis: recent findings].
    Angeli A; Osella G; Reimondo G; Terzolo M
    Ann Ital Med Int; 2000; 15(1):47-55. PubMed ID: 10842891
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Corticosteroid osteoporosis.
    Sambrook P; Lane NE
    Best Pract Res Clin Rheumatol; 2001 Jul; 15(3):401-13. PubMed ID: 11485337
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bone histomorphometry in the pathophysiological evaluation of primary and secondary osteoporosis and various treatment modalities.
    Steiniche T
    APMIS Suppl; 1995; 51():1-44. PubMed ID: 7669370
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Preventive effects of berberine on glucocorticoid-induced osteoporosis in rats.
    Xu D; Yang W; Zhou C; Liu Y; Xu B
    Planta Med; 2010 Nov; 76(16):1809-13. PubMed ID: 20577944
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The pathogenesis, epidemiology and management of glucocorticoid-induced osteoporosis.
    van Staa TP
    Calcif Tissue Int; 2006 Sep; 79(3):129-37. PubMed ID: 16969593
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Glucocorticoid-induced osteoporosis: an osteoblastic disease.
    Migliaccio S; Brama M; Fornari R; Greco EA; Spera G; Malavolta N
    Aging Clin Exp Res; 2007 Jun; 19(3 Suppl):5-10. PubMed ID: 18180599
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bone loss in premenopausal women on long-term suppressive therapy with thyroid hormone.
    Sijanovic S; Karner I
    Medscape Womens Health; 2001 Oct; 6(5):3. PubMed ID: 11698925
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Glucocorticoid-induced osteoporosis: review and proposition for prevention and treatment guidelines].
    Grazio S; Korsić M; Anić B; Vitezić-Misjak M; Grubisić F
    Lijec Vjesn; 2005; 127(1-2):36-43. PubMed ID: 16145872
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Glucocorticoid-induced osteoporosis: prevention and treatment.
    Ziegler R; Kasperk C
    Steroids; 1998; 63(5-6):344-8. PubMed ID: 9618799
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.